Effects of phase III cardiac rehabilitation on mortality and cardiovascular events in elderly patients with stable coronary artery disease

Circ J. 2010 Apr;74(4):709-14. doi: 10.1253/circj.cj-09-0638. Epub 2010 Mar 6.

Abstract

Background: Cardiac rehabilitation (CR) has numerous benefits, including reduction of mortality and cardiovascular events, in patients with coronary artery disease (CAD). However, the long-term effect of phase III CR in elderly patients with stable CAD is still unknown.

Methods and results: The 111 elderly male CAD patients (>or=65 years), including 37 subjects participating in supervised CR for 6 months and 74 age-matched controls, were analyzed. The patients were followed for up to 3,500 days, until the occurrence of death or 1 of the following major adverse cardiovascular events (MACE): cardiovascular death, acute coronary syndrome, refractory angina requiring revascularization, admission for congestive heart failure, or stroke. All-cause mortality tended to be lower in the CR group than in the Control group (14% vs 28%, P=0.081). The MACE incidence was significantly lower in the CR group than in the Control group (30% vs 62%, P=0.001). Multivariate Cox proportional hazard analysis showed that the MACE incidence was significantly lower in the CR group than in the Control group [adjusted hazard ratio 0.43 (95% confidence interval 0.20-0.91), P=0.027].

Conclusions: Phase III CR has the beneficial effect of reducing cardiovascular events even in elderly patients with stable CAD.

Publication types

  • Clinical Trial, Phase III
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Coronary Syndrome / epidemiology*
  • Acute Coronary Syndrome / mortality
  • Aged
  • Blood Glucose / metabolism
  • Body Mass Index
  • Coronary Artery Disease / blood
  • Coronary Artery Disease / rehabilitation*
  • Diet*
  • Exercise Therapy*
  • Follow-Up Studies
  • Heart Failure / epidemiology*
  • Heart Failure / mortality
  • Humans
  • Incidence
  • Japan
  • Lipids / blood
  • Male
  • Patient Education as Topic*
  • Proportional Hazards Models
  • Stroke / epidemiology*
  • Stroke / mortality
  • Treatment Outcome

Substances

  • Blood Glucose
  • Lipids